In minor, nondisabling, acute ischemic stroke, DAPT was noninferior to IV alteplase for excellent functional outcome at 90 d

Carly Eastin

doi:10.7326/J23-0072

In minor, nondisabling, acute ischemic stroke, DAPT was noninferior to IV alteplase for excellent functional outcome at 90 d

Ann Intern Med. 2023 Oct;176(10):JC110. doi: 10.7326/J23-0072. Epub 2023 Oct 3.

Author

Carly Eastin¹

Affiliation

¹ University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (C.E.).

PMID: 37782921
DOI: 10.7326/J23-0072

Abstract

Chen HS, Cui Y, Zhou ZH, et al; ARAMIS Investigators. Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial. JAMA. 2023;329:2135-2144. 37367978.

Publication types

Randomized Controlled Trial
Comment

MeSH terms

Humans
Ischemic Stroke* / drug therapy
Platelet Aggregation Inhibitors / therapeutic use
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Tissue Plasminogen Activator